CMAC 2005; 7(2) | CMAC

CMAC 2005; 7(2)

To cause an infection viruses have to overcome diverse host defense mechanisms. The system exploited in certain human cells to prevent …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):112-118
PDF

Survey of up-to-date knowledge of rickettsioses, their geographical distribution, importance for the infectious pathology, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):119-129
PDF

According to the guidelines of ESCAR (ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella and the European Network for …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):130-153
PDF

The present analyzed study the level, structure and phenotypes of antimicrobial resistance of Streptococcus pyogenes in different …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):154-166
PDF

The problem of counterfeit drugs was first discussed at international level in 1985 at the World Health Organization Conference of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):167-173
PDF

Urinary tract infections are one of the most prevalent community-acquired diseases. One of the crucial moments in the therapy of these …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):174-182
PDF

In the treatment of uncomplicated urinary tract infec-tions the following groups of antimicrobial are of clinical use: …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):183-188
PDF

The literature devoted to the Candida infections in very-low-birth-weight neonates was reviewed using the Medline and Cochrane …
Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):189-196
PDF